| Professional profile/background: |
|
Stephen qualified from Liverpool University in 1983 and spent a
period in Liverpool undertaking a general medical rotation.
He then trained in oncology in Cardiff and Cambridge, becoming a
consultant in Bristol in 1994.
He has sessional commitments to Southmead Hospital in Bristol
and attends the Taunton Nuffield Hospital. His major clinical
interests are thoracic (lung) and gastro-intestinal
malignancies (oesophagus, stomach, pancreas, colo-rectal).
Interest in lung cancer and clinical research was stimulated as a
MRC Clinical Scientist in Norman Bleehens' Unit in Cambridge where
the MRC cancer trials unit was situated at the time. A MD
related to lung cancer and scheduling of topoisomerase poisons with
and without radiation is the basis of on-going interest in
chemo-radiation interactions. He has a major interest in
research and where possible all patients who are referred will be
offered an appropriate clinical trial.
Until recently a challenging clinical load has seen up to 1000
new patients with cancer annually, but now is spending
more time as clinical lead for research and development within
the Bristol Haematology and Oncology centre and for the National
Cancer Research Network locally in Avon Somerset and Wiltshire.
Stephen is now Clinical Director of the Western
Comprehensive Local Research network whose job is to fund the NHS
costs of delivering research activity in the NHS. He is also a
member of the NCRI upper GI studies group and of the
major fund awarding bodies related to the NCRN, including
Cancer Research UK.
He is head of Clinical Oncology (radiotherapy) in Bristol, and
a member of the editorial board of the journal Clinical Oncology.
He is an author in more than 45 publications.
|
